The goal of HSCT

The goal of HSCT is to stop the increasing neurological damage. A recent analysis of studies show that 67% of patients who have had HSCT had no evidence of disease activity after 5 years. It is seen as a more effective way than through inhibition drugs (source: 32nd Annual International Congress of ECTRIMS Neurologists, September 2016). The best results are achieved with people that have the aggressive, episodic type of MS (which Martine does not have).

It’s possible that there will be some recovery of the insulation around the nerves, but this is not guaranteed. Sometimes there is permanent damage that can not be restored. The chance of improvement with the type of MS that Martine has (secondary progressive) is small. After two years it can be determined definitely whether the MS has been stopped.